The conference is hosted by the Norwegian Centre for Addiction Research (SERAF) at the University of Oslo, with support from the National overdose prevention strategy The Directorate of Health).
The conference will be held in English.
Programme
Session topic |
Time |
Speaker |
Title |
---|---|---|---|
Registration & Coffee |
8:30 |
|
|
Setting the scene |
9:00 |
Thomas Clausen, Philipp Lobmaier, Martin Blindheim |
Welcome address |
The origins and future of bystander administered naloxone |
9:10 |
Maya Doe-Simkins |
Overview of American naloxone efforts: activism, public health, and a changing opioid landscape
|
High risk for ODs: prison inmates and the elderly
|
9:40
|
Thomas Clausen |
The influence of ageing among opioid users in the Nordics on OD mortality rates |
10:00 |
Kirsten Horsburgh |
Naloxone upon prison release: lessons and results from the Scottish national initiative |
|
10:30 |
Sharon Stancliff |
Naloxone in the US criminal justice system and among law enforcers |
|
Coffee and Refreshments |
11:00 |
30 min break |
|
Implementations, primary care and standardizing |
11:30 |
Desiree Madah-Amiri |
The Norwegian naloxone program; Experiences from implementing and results |
11:50 |
Alex Walley |
Expanded access to naloxone: Standing orders, pharmacy access, and co-prescribing |
|
Planning naloxone research |
12:30 |
Philipp Lobmaier & panel of volunteers |
Co-operations across countries, industries and funding agencies |
Lunch |
13:00 |
60 min break |
|
Fentanyls |
14:00 |
Ola Dale |
Clinical pharmacological aspects of heroin and fentanyl overdoses |
14:30 |
Alex Walley |
Moving target; opioid epidemic dynamics and consequences for interventions in the era of fentanyl |
|
Coffee, tea, scones |
15:00 |
20 min break |
|
Northern European countries and national strategies |
15:20 |
Kristel Kivimets |
The Estonian naloxone experience |
15:40 |
Andy McAuley |
Five years of a national naloxone programme in Scotland: what have we learned? |
|
16:00 |
Martin Blindheim |
The Norwegian national strategy for overdose death prevention |
|
Further development of take home naloxone |
16:20 |
Sir John Strang |
Developments in take-home naloxone: a global perspective on future devices |
Closing up |
16:50 |
Clausen, Lobmaier, Blindheim |
Final remarks |
Meeting ends |
17:00 |
|
|
Apéritif |
17:30 |
||
Conference dinner |
18:00 |